The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and clinical activity of pembrolizumab immunotherapy and multi-organ site ablative stereotactic body radiotherapy (iMOSART) in patients with advanced solid tumors.
 
Jeffrey Lemons
No Relationships to Disclose
 
Jason J. Luke
Honoraria - Intellisphere, LLC
Consulting or Advisory Role - 7 Hills Pharma; Amgen; Array BioPharma; AstraZeneca/MedImmune; Benevir; Bristol-Myers Squibb; Castle Biosciences; Checkmate Pharmaceuticals; EMD Serono; Merck; Novartis
Research Funding - Abbvie; Boston Biomedical; Bristol-Myers Squibb; Celldex; Corvus Pharmaceuticals; Delcath Systems; Five Prime Therapeutics; Genentech/Roche; Immunocore; Incyte; MedImmune; Merck; Pharmacyclics
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Theodore Karrison
No Relationships to Disclose
 
Sean Pitroda
No Relationships to Disclose
 
James Melotek
No Relationships to Disclose
 
Yuanyuan Zha
No Relationships to Disclose
 
Hania A Al-Hallaq
Honoraria - Reflexion Medical
Patents, Royalties, Other Intellectual Property - University of Chicago Computer Aided Diagnosis
 
Ainhoa Arina
No Relationships to Disclose
 
Linda A. Janisch
No Relationships to Disclose
 
Paul J Chang
No Relationships to Disclose
 
Jyoti D. Patel
Consulting or Advisory Role - Abbvie; ARIAD
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
Other Relationship - Aeterna Zentaris
 
John William Moroney
No Relationships to Disclose
 
Manish Sharma
Consulting or Advisory Role - Abbvie; Bayer; Ipsen; Taiho Pharmaceutical
 
Julia R. White
Honoraria - Qfix
 
Mark J. Ratain
Stock and Other Ownership Interests - Biscayne Pharmaceuticals; PrescriptIQ; Venaxis
Consulting or Advisory Role - AbbVie; Amgen; Biomarin; Biscayne Pharmaceuticals; Circle Pharma; Cyclacel; Drais Pharmaceuticals; Genentech/Roche; Portola Pharmaceuticals; Shionogi; Venaxis
Research Funding - Dicerna (Inst); OncoTherapy Science (Inst)
Patents, Royalties, Other Intellectual Property - pending patent related to a genomic prescribing system; pending patent related to a genomic prescribing system (Inst); royalties related to UGT1A1 genotyping for irinotecan; royalties related to UGT1A1 genotyping for irinotecan (Inst)
Expert Testimony - multiple generic companies
 
Thomas Gajewski
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; FORMA Therapeutics; Jounce Therapeutics; Merck; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Licensing to Evelo (Inst)
 
Ralph R. Weichselbaum
Stock and Other Ownership Interests - Catherex
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - AstraZeneca; Merck KGaA
Research Funding - Regeneron; Varian Medical Systems
 
Steven J. Chmura
No Relationships to Disclose